Mohammadi G, Jamialahmadi K, Lary S, Ghaffarzadegan K
Department of Biology, Payam Noor University of Mashhad, Mashhad, Iran.
Pak J Biol Sci. 2011 Mar 1;14(5):357-62. doi: 10.3923/pjbs.2011.357.362.
The aim of this study was to investigate the expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and it's correlation with clinicopathological features. Fifty formalin-fixed, paraffin embedded archival specimens of colorectal cancer were included randomly as cases. Immunohistochemical staining was performed to assess EGFR expression. The results were correlated with the clinicopathological features of colorectal tumor tissues. More than 1% of membranous EGFR expression was found in 24 (48%) of cancer specimens. The immunoreactions intensity was classified as weak, moderate and strong representing 2, 22 and 24%, respectively. According to multivariate analysis, EGFR expression was not significantly associated with age, sex, tumor site, stage, grade and type of tumor in cases. These results suggest that the assessment of EGFR expression in colorectal cancer by conventional immunohistochemistry has not proven its predictive value and can not be useful to predict about outcome of patients.
本研究旨在探讨膜表皮生长因子受体在结直肠癌中的表达及其与临床病理特征的相关性。随机纳入50例经福尔马林固定、石蜡包埋的结直肠癌存档标本作为病例。采用免疫组织化学染色评估表皮生长因子受体(EGFR)的表达。结果与结直肠肿瘤组织的临床病理特征相关。在24例(48%)癌标本中发现膜性EGFR表达超过1%。免疫反应强度分为弱、中、强,分别占2%、22%和24%。根据多因素分析,病例中的EGFR表达与年龄、性别、肿瘤部位、分期、分级和肿瘤类型无显著相关性。这些结果表明,通过传统免疫组织化学评估结直肠癌中的EGFR表达尚未证实其预测价值,对预测患者的预后并无帮助。